Rigel Pharmaceuticals Inc (RIGL)
1.13
-0.01
(-0.88%)
USD |
NASDAQ |
Apr 24, 16:00
1.13
0.00 (0.00%)
After-Hours: 20:00
Rigel Pharmaceuticals Cash from Operations (TTM): -5.743M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -5.743M |
| September 30, 2023 | -21.41M |
| June 30, 2023 | -33.35M |
| March 31, 2023 | -52.20M |
| December 31, 2022 | -73.76M |
| September 30, 2022 | -70.94M |
| June 30, 2022 | -67.93M |
| March 31, 2022 | 0.196M |
| December 31, 2021 | 5.878M |
| September 30, 2021 | 9.392M |
| June 30, 2021 | 0.207M |
| March 31, 2021 | -69.05M |
| December 31, 2020 | -52.18M |
| September 30, 2020 | -46.26M |
| June 30, 2020 | -41.42M |
| March 31, 2020 | -44.03M |
| December 31, 2019 | -41.51M |
| September 30, 2019 | -20.22M |
| June 30, 2019 | -25.66M |
| March 31, 2019 | -36.00M |
| December 31, 2018 | -58.83M |
| September 30, 2018 | -90.18M |
| June 30, 2018 | -87.71M |
| March 31, 2018 | -80.19M |
| December 31, 2017 | -77.56M |
| Date | Value |
|---|---|
| September 30, 2017 | -70.31M |
| June 30, 2017 | -75.27M |
| March 31, 2017 | -74.23M |
| December 31, 2016 | -75.89M |
| September 30, 2016 | -77.22M |
| June 30, 2016 | -64.11M |
| March 31, 2016 | -63.82M |
| December 31, 2015 | -23.41M |
| September 30, 2015 | -24.62M |
| June 30, 2015 | -33.54M |
| March 31, 2015 | -35.34M |
| December 31, 2014 | -69.75M |
| September 30, 2014 | -73.65M |
| June 30, 2014 | -76.02M |
| March 31, 2014 | -77.39M |
| December 31, 2013 | -86.08M |
| September 30, 2013 | -88.75M |
| June 30, 2013 | -87.63M |
| March 31, 2013 | -87.05M |
| December 31, 2012 | -85.21M |
| September 30, 2012 | -82.29M |
| June 30, 2012 | -75.46M |
| March 31, 2012 | -71.88M |
| December 31, 2011 | -69.38M |
| September 30, 2011 | -40.45M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-73.76M
Minimum
Dec 2022
9.392M
Maximum
Sep 2021
-34.21M
Average
-41.42M
Median
Jun 2020
Cash from Operations (TTM) Benchmarks
| Nektar Therapeutics | -192.61M |
| Avid Bioservices Inc | 1.705M |
| Stereotaxis Inc | -9.139M |
| Cara Therapeutics Inc | -92.08M |
| Blueprint Medicines Corp | -436.85M |